Home / Research Articles Hub / Spatial CRISPR genomics identifies regulators of t...
🧬 Medicine & Biology PubMed

Spatial CRISPR genomics identifies regulators of the tumor microenvironment.

📅 Published: March 31, 2022 👤 Dhainaut Maxime, Rose Samuel A, Akturk Guray et al. 📖 Cell
AI-Generated Summary

While CRISPR screens are helping uncover genes regulating many cell-intrinsic processes, existing approaches are suboptimal for identifying extracellular gene functions, particularly in the tissue context. We found that in Tgfbr2 knockout tumors, the tumor microenvironment (TME) was converted to a fibro-mucinous state, and T cells excluded, concomitant with upregulated TGFβ and TGFβ-mediated fibroblast activation, indicating that TGFβ-receptor loss on cancer cells increased TGFβ bioavailability...

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

Key Findings
  • 1 Here, we developed an approach for spatial functional genomics called Perturb-map.
  • 2 We applied Perturb-map to knock out dozens of genes in parallel in a mouse model of lung cancer and simultaneously assessed how each knockout influenced tumor growth, histopathology, and immune composition.
  • 3 Moreover, we paired Perturb-map and spatial transcriptomics for unbiased analysis of CRISPR-edited tumors.
Why It Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source:

Read Full Paper at PubMed
More Medicine & Biology Papers ← Back to Hub 📚 Learning Hub